Skip to content!
Dr. Michael Allan Ribers

Dr. Michael Allan Ribers

Research Associate of the

Firms and Markets Department

Contact

+49 30 89789 - 518
mribers@diw.de
Vcard
hayek.diw.de/cv/en/mribers

Publications

DIW Wochenbericht 13/14 / 2021

Der gesellschaftliche Mehrwert verknüpfter Daten: Algorithmen als Entscheidungshilfen bei Antibiotikaverschreibungen

2021| Shan Huang, Michael Allan Ribers, Hannes Ullrich
Diskussionspapiere 1939 / 2021

The Value of Data for Prediction Policy Problems: Evidence from Antibiotic Prescribing

2021| Shan Huang, Michael Allan Ribers, Hannes Ullrich
Externe referierte Aufsätze

Assessing the Value of Data for Prediction Policies: The Case of Antibiotic Prescribing

In: Economics Letters 213 (2022), 110360, 4 S. | Shan Huang, Michael Allan Ribers, Hannes Ullrich

Lectures

Vortrag

Machine Predictions and Human Decisions with Variation in Payoffs and Skill

Michael Ribers, Hannes Ullrich
Toulouse, Frankreich, 06.12.2021 | Workshop on the Economics of Antibiotics: Toulouse School of Economics
Vortrag

Machine Predictions and Human Decisions with Variation in Payoffs and Skill

Michael Ribers, Hannes Ullrich
Essen, 29.11.2021 | Essen Health Economics Seminar
Vortrag

Using Machine Learning and Administrative Data to Understand and Improve Antibiotic Prescribing in General Practice

Shan Huang, Michael Ribers, Hannes Ullrich
[Online], 11.11.2021 | EPRN Seminar: Danish Ministry of Health and Department of Economics, University of Copenhagen [Online]
Vortrag

Machine Predictions and Human Decisions with Variation in Payoffs and Skill

Michael Ribers, Hannes Ullrich
Mannheim, 26.10.2021 | CRC TR 224 Economics Seminar: Universität Mannheim
Vortrag

Machine Predictions and Human Decisions with Variation in Payoffs and Skill

Michael Ribers, Hannes Ullrich
[Online], 21.06.2021 - 23.06.2021| AShecon 2021 - 10th Annual Conference of the American Society of Health Economists [Online]

Research Projects

Research Project

Antibiotic Resistance: Socio-Economic Determinants and the Role of Information and Salience in Treatment Choice (ABRSEIST)

Current Project| Firms and Markets
keyboard_arrow_up